Haemapheresis Conference in the Netherlands NL. The Hague,21.-22. November 2024 Novel Boundaries in Haemapheresis and Cell Therapy Link for Regisrtation:  https://www.haemapheresisconference.nl/ REMINDER: Deadline for Abstract submission: 3. November 2024 PREVIOUS Important CAR-T WebinarWednesday, February 22, 2023, 3 pm to 4:30 pm (GMT+1) The European Society for Hemapheresis is happy to host, in collaborationwith Terumo Blood and Cell technologies, an update on CAR-T with twoexperts from the HospitalClínic of Barcelona in Spain Dr. Miquel LozanoMononuclear cell collection for CAR-T therapies , Dr. Julio DelgadoNovel applications of CAR-T therapies    UPDATE from the22nd ESFH CONGRESS    held as ahybrid joint meeting of the Turkish Hematology Society, WAA and ESFH September 14th – 17th, 2022, Istanbul, Turkey AWARDS: Abstract Award(Certificate 500€) Dr.SerraAltuntas Title:Is there any predictive laboratory parameter to predict the success of hemoadsorption in Sepsis Co-Authors: Altuntas S, Yigenoglu TN, Basci S, Durmusoglu E, Silgeciler H, Kilinc A, Altuntas F., Yüksek Ihtisas University, Faculty of Medicine. Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital. Helmut Borberg Award Dr. Bernd Stegmayr  Senior Prof. of UMEA University, Sweden,  Department ofPublic Health and Clinical Medicine Title of the lecture: My reflections of the therapeutic power and risks of various apheresis approaches”   Update PROGRAM  andContent for downloadof the 21st  Congress    2021,  May 26th - 27th  Digital       Presentations  and Session Videos H. Vrielink Convalescent Plasma: from whom and when (pdf)  VideoHans Vrielink  MD PhD: Convalescent plasma: from whom and when M.Lozano  Apheresis techniques in the treatment of severe COVID-19 patients (pdf) Video:Miquel Lozano: Apheresis techniques in the treatment of severe COVID-19 patients L.Pierelli  Clinical impact of allogeneic stem cells cryopreservation during COVID-19 pandemic(pdf) Video  Luca Pierell:Clinical impact of allogeneic stem cells cryopreservation during COVID-19 pandemic M.-J Mustieles:Vascular Aaccess: Always Central Line?  (pdf) Video  M.J. Mustieles:Vascular Aaccess: Always Central Line? Video Marie Scully:New treatment strategies in management of TTP     Presentations  and Session Videos H. Vrielink Convalescent Plasma: from whom and when (pdf)  VideoHans Vrielink  MD PhD: Convalescent plasma: from whom and when M.Lozano  Apheresis techniques in the treatment of severe COVID-19 patients (pdf) Video:Miquel Lozano: Apheresis techniques in the treatment of severe COVID-19 patients L.Pierelli  Clinical impact of allogeneic stem cells cryopreservation during COVID-19 pandemic(pdf) Video  Luca Pierell:Clinical impact of allogeneic stem cells cryopreservation during COVID-19 pandemic M.-J Mustieles:Vascular Aaccess: Always Central Line?  (pdf) Video  M.J. Mustieles:Vascular Aaccess: Always Central Line? Webinars produced  by  Terumo BCT with the collaboration of ESFH Previous WAA  WEBINAR September 15, 2021, 12:00 pm -2:00pm (EST) Role of Apheresis in Cellular Therapies and Thrombosis Following COVID- 19  https://us02web.zoom.us/webinar/register/WN_61FziquaSTGXv7uj0R1DiQ Webinar  “How to optimize blood transfusion treatment outcomes for SCD patients?” On-Demand WebinarOne Year In: Lessons Learned About Transfusion of Convalescent Plasma (CP) for COVID-19 Presented by Dr. Miquel Lozano, Chief, Hemotherapy Section, Hospital Clinic de Barcelona, Spain Dr. Claudia Cohn, Chief Medical Officer, AABB Dr. Leandro Burgos Pratx, Executive Chief of the Service of Transfusion Medicine, Hospital Italiano of Buenos Aires, Brazil Dr. Silvano Wendel, Medical Director, Hospital Sirio Libanes São Paulo, Brazil Deirdre Fehily, PhD, Policy Officer – Substances of Human Origin Team, European Commission